Clinical trial
A Randomized, Multicenter, Phase III Trial Comparing Induction CT With Docetaxel, Cisplatin and 5-FU (TPF) Followed by Concurrent CT-RT to Concurrent CT Alone, in Nasopharyngeal Cancers Staged as T2b, T3, T4 and/or With Lymph Node Involvement (>N1)
NCT00828386 is registered in ClinicalTrials.gov with Groupe Oncologie Radiotherapie Tete et Cou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter, Phase III Trial Comparing Induction CT With Docetaxel, Cisplatin and 5-FU (TPF) Followed by Concurrent CT-RT to Concurrent CT Alone, in Nasopharyngeal Cancers Staged as T2b, T3, T4 and/or With Lymph Node Involvement (>N1)
- Lead sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2009
- Completion date
- April 19, 2017
- Enrollment
- 83 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
nasopharyngeal cancers